LCI News and Press, Lannett Co Inc From 01/21/22

LANNETT ANNOUNCES FDA COMPLETES REVIEW OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR BIOSIMILAR INSULIN GLARGINE --FDA States Pivotal Clinical Trial May Proceed, Trial Expected to Commence By March 2022-- PR Newswire PHILADELPHIA , Jan. 21, 2022 /PRNewswi...

LANNETT ANNOUNCES SUBMISSION OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR BIOSIMILAR INSULIN GLARGINE --Company Anticipates Commencing Pivotal Clinical Trial in March 2022-- PR Newswire PHILADELPHIA , Dec. 20, 2021 /PRNewswire/ -- Lannett Company, Inc. (...

Lannett Company, Inc. (LCI) Q1 2022 Earnings Conference Call November 3, 2021 04:30 PM ET Company Participants Robert Jaffe - Investor Relations Tim Crew - Chief Executive Officer John Kozlowski - Chief Financial Officer Conference Call Participants Scott Henry - ROTH Capital Partners, LLC Pr...

Image source: The Motley Fool. Lannett Company, inc (NYSE: LCI) Q1 2022 Earnings Call Nov 3, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Lannett Company, inc (LCI) Q1 2022 Earnings Call Transcript

Lannett (NYSE:LCI): Q1 Non-GAAP EPS of -$0.27 misses by $0.03; GAAP EPS of -$0.56 misses by $0.28. Revenue of $101.5M (-19.8% Y/Y) beats by $2.88M. Press Release For further details see: Lannett EPS misses by $0.03, beats on revenue

Lannett Reports Fiscal 2022 First-Quarter Financial Results; Revises Down Full-year Guidance --Company Announces Restructuring Plan Targeting $20 Million in Reduced Expenses, To Consolidate Manufacturing Operations and Restructure the R&D Function-- - Q1 Business and Fin...

Lannett To Report Fiscal 2022 First-quarter Financial Results, Host Conference Call On Wednesday, November 3 PR Newswire PHILADELPHIA , Oct. 28, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its f...

Lannett Commences Marketing Mycophenolate Mofetil For Oral Suspension PR Newswire PHILADELPHIA , Aug. 30, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced marketing Mycophenolate Mofetil for Oral Suspension USP, 200 mg/...

Image source: The Motley Fool. Lannett Company, inc (NYSE: LCI) Q4 2021 Earnings Call Aug 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Lannett Company, inc (LCI) Q4 2021 Earnings Call Transcript

Lannett Company, Inc. (LCI) Q4 2021 Earnings Conference Call August 25, 2021, 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Tim Crew - Chief Executive Officer John Kozlowski - Chief Financial Officer Maureen Cavanaugh - Chief Commercial Operations Officer Steve Lehrer - Le...